Brevetti EPO No.2846780 2018.07.18
Brevetti EPO
(10) Registration Number and Date
2018000506 2018.10.03
Status
Expired
(180) Expiration Date
(20) Filing Number and Date
SM /T/2018/000506 2013.04.30
(40) Publication Number and Date
SM /T/2018/000506 2018.10.03
(30) Priority Details
US 201261643454 P
2012.05.07
(51) IPC Classes
(72) Inventor
(IT) PERRONE, Robert Kevin : c/o Bristol-Myers Squibb Company1 Squibb Drive, New Brunswick, New Jersey 08903, US
(74) Representative Name
(IT) CATALDI, Silvia : Via Consiglio dei Sessanta, 99, 47891 Dogana, SM
(54) Title
(IT) FORMULAZIONE IN CAPSULE SOLUBILIZZATE DI 1,1-DIMETILETIL[(1S)-1-{[(2S,4R)-4-(7-CLORO-4METOSSIISOCHINOLIN-1-ILOSSI)-2-({(1R,2S)-1-[(CICLOPROPILSOLFONIL)CARBAMOIL]-2-ETENILCICLOPROPIL}CARBAMOIL)PIRROLIDIN-1-IL]CARBONIL}-2,2-DIMETILPROPIL]CARBAMMATO
(EN) SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-{[(2S,4R)-4-(7-CHLORO-4METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2020.06.09
Event NameDateStatus
Filing2013.04.30Filed
Brevetto EPO concesso2018.10.03Published
Ricevuta pagamento annualita 72019.03.28Payed
Decaduto per non pagamento tassa2020.11.09Expired